Presence Of Cancer-Associated Fibroblasts Inversely Correlates With Schwannian Stroma In Neuroblastoma Tumors

Stromal cells have a central function in the regulation of tumor angiogenesis. Recent studies have shown that stromal myofibroblasts (cancer-associated fibroblasts) actively promote tumor growth and enhance tumor angiogenesis in many types of adult carcinomas. To evaluate the function cancer-associated fibroblasts have in neuroblastoma angiogenesis and investigate their relationship to stromal Schwann cells, we quantified cancer-associated fibroblasts in 60 primary neuroblastoma tumors and in a novel neuroblastoma xenograft model in which murine Schwann cells were induced to infiltrate into the tumor stroma. Tumor sections were examined for presence of microvascular proliferation, a hallmark of tumor angiogenesis. Cancer-associated fibroblasts were characterized by positive immunostaining for α-smooth muscle actin (α-SMA) and were distinguished from pericytes by staining negatively for high-molecular-weight caldesmon. α-SMA-positive cells were quantified and their number was defined as high when >1.0% of the area was positive. Associations between high cancer-associated fibroblast number, microvascular proliferation and established prognosticators were analyzed. High numbers of cancer-associated fibroblasts were associated with Schwannian stroma-poor histopathology and microvascular proliferation. Thirty-seven (80%) of the 46 Schwannian stroma-poor tumors had high numbers of cancer-associated fibroblasts in the tumor stroma compared to only 2 (14%) of the 14 Schwannian stroma-rich/dominant tumors (P<0.001). Thirty-three (89%) of 37 tumors with microvascular proliferation had high numbers of cancer-associated fibroblasts compared to 9 (40%) of 22 tumors without microvascular proliferation (P<0.001). In the xenografts with infiltrating Schwann cells (n=10), the number of cancer-associated fibroblasts per mm2 was approximately sevenfold less than in the control xenografts without stromal Schwann cells (n=9) (mean of 51±30 vs 368±105, respectively; P<0.001). Thus, cancer-associated fibroblasts were inversely associated with presence of Schwann cells, suggesting that Schwann cells may prevent the activation of fibroblasts. A deeper understanding of the function cancer-associated fibroblasts have in neuroblastoma angiogenesis may guide future development of stroma-directed therapeutic strategies.

[1]  A. Look,et al.  Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study. , 2001, Neoplasia.

[2]  G. Watkins,et al.  The HGF/SF antagonist NK4 reverses fibroblast‐ and HGF‐induced prostate tumor growth and angiogenesis in vivo , 2003, International journal of cancer.

[3]  Giulio Gabbiani,et al.  The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. , 2004, The International journal of developmental biology.

[4]  A. Ostman,et al.  Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? , 2004, Lung cancer.

[5]  Zhang Weidong,et al.  Clinicopathological Significance of Stromal Myofibroblasts in Invasive Ductal Carcinoma of the Breast , 2004, Tumor Biology.

[6]  A. Nakagawara,et al.  Prognostic VaIue of N‐myc Oncogene Amplification and S‐100 Protein Positivity in Children with Neuroblastic Tumors , 1992, Acta pathologica japonica.

[7]  S. Cohn,et al.  SPARC enhances tumor stroma formation and prevents fibroblast activation , 2007, Oncogene.

[8]  J. Bowen,et al.  Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors. , 2005, Archives of pathology & laboratory medicine.

[9]  K. Matsumoto,et al.  Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. , 1997, Cancer research.

[10]  Qiwei Yang,et al.  Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts. , 2005, The American journal of pathology.

[11]  K. Cole,et al.  Prominent Microvascular Proliferation in Clinically Aggressive Neuroblastoma , 2007, Clinical Cancer Research.

[12]  Hiroyuki Shimada,et al.  Terminology and morphologic criteria of neuroblastic tumors , 1999, Cancer.

[13]  Qiwei Yang,et al.  Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma. , 2003, Cancer research.

[14]  H. B. Marsden,et al.  Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. , 1984, Journal of the National Cancer Institute.

[15]  Olivier De Wever,et al.  Role of tissue stroma in cancer cell invasion , 2003, The Journal of pathology.

[16]  O. Volpert,et al.  Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. , 2001, Journal of cell science.

[17]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[18]  W. Frankel,et al.  Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles , 2004, Oncogene.

[19]  J. Nesland,et al.  Activation of EDTA-resistant gelatinases in malignant human tumors. , 2006, Cancer research.

[20]  K K Matthay,et al.  The International Neuroblastoma Pathology Classification (the Shimada system) , 1999, Cancer.

[21]  O. Petersen,et al.  Smooth muscle differentiation in cultured human breast gland stromal cells. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[22]  M. A. Huber,et al.  Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. , 2003, The Journal of investigative dermatology.

[23]  T. Nakamura,et al.  Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. , 2003, Carcinogenesis.

[24]  J. Park,et al.  Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts* , 1999, The Journal of Biological Chemistry.

[25]  Webster K. Cavenee,et al.  Pathology and genetics of tumours of the nervous system. , 2000 .

[26]  O. Volpert,et al.  SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. , 2002, Cancer research.

[27]  E. Ross,et al.  Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer , 2007, Clinical Cancer Research.

[28]  L. Orci,et al.  Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[29]  C. R. Pinkerton,et al.  International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. , 1988, Progress in clinical and biological research.

[30]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[31]  A. Rademaker,et al.  Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  M. Tsuneyoshi,et al.  S-100 positive undifferentiated neuroblastomas with a special reference to the tumor stroma related to favorable prognosis. , 1992, Pathology, research and practice.

[33]  G. Ayala,et al.  Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. , 2002, Cancer research.

[34]  G. Ayala,et al.  Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  Mark W. Kieran,et al.  Identification of fibroblast heterogeneity in the tumor microenvironment , 2006, Cancer biology & therapy.

[36]  A. Rojiani,et al.  Glomeruloid vascular structures in glioblastoma multiforme: an immunohistochemical and ultrastructural study. , 1996, Journal of neurosurgery.